Reliant AI
2026
Why
Montreal- and Berlin-based biopharma AI company acquired in May 2026 to expand Cohere's sovereign AI offering for healthcare and life sciences.
Cohere Inc.
Acquisitions
3
Major Deals Covered
This page covers 3 major deals from 2025 to 2026, each with its price where disclosed and the reason behind it.
| Company | Year | Price | Purpose |
|---|---|---|---|
| Ottogrid | 2025 | Undisclosed | Vancouver-based startup automating market research and data enrichment; acquired in May 2025. |
| Reliant AI | 2026 | Undisclosed | Montreal- and Berlin-based biopharma AI company acquired in May 2026 to expand Cohere's sovereign AI offering for healthcare and life sciences. |
| Aleph Alpha | 2026 | Undisclosed | Merger with the Heidelberg-based German AI company, announced April 2026 and formalized in a definitive agreement on September 16, 2026; pending regulatory approval. Terms were not disclosed; the combined company was reported at ~$20 billion. |
2026
Montreal- and Berlin-based biopharma AI company acquired in May 2026 to expand Cohere's sovereign AI offering for healthcare and life sciences.
2026
Merger with the Heidelberg-based German AI company, announced April 2026 and formalized in a definitive agreement on September 16, 2026; pending regulatory approval. Terms were not disclosed; the combined company was reported at ~$20 billion.
2025
Vancouver-based startup automating market research and data enrichment; acquired in May 2025.
Cohere's growth strategy has shifted from selling raw model APIs to selling complete, privately deployable AI systems. Key moves include the North agent platform (2025), acquisitions of Ottogrid (2025), Reliant AI (May 2026) and the pending Aleph Alpha merger, new offices in Paris and Seoul, and partnerships with cloud and software vendors including Oracle, Fujitsu, OpenText and Schwarz Group's STACKIT. The aim is to become the default AI supplier for governments and regulated industries that want an alternative to US hyperscaler-controlled models.
Cohere makes money by selling AI to businesses, not consumers. Customers pay per token to call its Command, Embed and Rerank models through Cohere's own API or cloud marketplaces such as Oracle Cloud Infrastructure, Amazon Bedrock and Microsoft Azure. Larger customers sign annual contracts for private deployments, where Cohere's models and its North agent platform run inside the customer's virtual private cloud or on-premise hardware so confidential data never leaves their control. Cohere also earns revenue from custom model work and sovereign AI projects with governments and national champions, such as its Japanese-language work with Fujitsu and the planned partnership with Schwarz Group's STACKIT cloud in Europe.
Cohere acquired Vancouver market research startup Ottogrid in May 2025 and Montreal- and Berlin-based biopharma AI company Reliant AI in May 2026, and signed a definitive agreement to merge with Germany's Aleph Alpha in September 2026.
The deal gives Cohere a German base, government support in Canada and Germany, and a ~$565 million (€500 million) investment from Schwarz Group, strengthening its pitch as a sovereign AI alternative to US providers in Europe.
Financial terms were not disclosed. Reports in April 2026 said the combined company would be valued around $20 billion, with Cohere shareholders holding about 90%.
Not as of October 1, 2026. The definitive agreement was signed on September 16, 2026, and the deal remains subject to regulatory approvals.
Reliant AI builds AI tools for biopharma research; the deal expands Cohere's North platform and sovereign AI offering into healthcare and life sciences.
No, but they have a massive, highly strategic alliance. Oracle is a major investor and aggressively embeds Cohere's generative AI models directly into Oracle's massive suite of enterprise software used by Fortune 500 companies.
Compare corporate acquisition records, deal values, and strategic targets
Explore Cohere
Core profile pages, founders and related research hubs for this company.